
Aegon, a Dutch insurance firm, is currently evaluating the prospect of relocating its head office and legal domicile to the US.
The consideration reflects the US’s contribution to Aegon’s business, accounting for around 70% of its operations and being integral to the company’s long-term growth plans.
The insurer has a workforce of 600 in the Netherlands, with the potential relocation to like affect roughly 250 employees, reported Bloomberg.
The potential move would also entail making the New York Stock Exchange an additional primary trading platform for Aegon’s shares, alongside its existing Amsterdam listing.
Aegon’s US subsidiary, Transamerica, specialises in providing life insurance, retirement, and investment solutions.
It particularly targets the middle-income demographic in the US, which Aegon identifies as relatively underserved, further highlighted Bloomberg.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAegon anticipates finalising the review in the forthcoming months, with further details to be disclosed at its capital markets day in December.
The transition, which may take between two to three years, involves the implementation of US GAAP accounting standards, a process that has already commenced.
Aegon CEO Lard Friese said:
“A relocation of Aegon’s legal domicile and head office to the United States is expected to simplify Aegon’s corporate structure as it would align its legal domicile, tax residency, accounting standard and regulatory framework with the geography where it conducts the majority of its business.”
The review follows Aegon’s decision to merge its Dutch operations with ASR Nederland in a transaction worth €4.9bn ($5.7bn).
Post-transaction in 2023, Aegon shifted its legal domicile to Bermuda due to the lack of a regulated insurance business in the Netherlands.
The company announced the US relocation plans along with its financial statement for the first half of 2025 (H1 2025).
The insurer
recorded a net profit of €606m in H1 2025, compared with a net loss of €65m during the same period the previous year. The operating result increased by 19% to €845m, driven by business growth and “improved experience variance” in the US market.